Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy

    Pediatrics
    |December 3, 2005
    PubMed

    Insights

    Duchenne and Becker muscular dystrophies cause progressive muscle weakness and cardiac issues. This policy provides guidelines for timely cardiovascular evaluation in affected individuals.

    Area of Science:

    • Neurology
    • Cardiology
    • Genetics

    Background:

    • Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are severe genetic disorders.
    • These conditions lead to progressive skeletal muscle weakness, respiratory compromise, and cardiac failure.
    • The natural history of cardiomyopathy in DMD and BMD is not well understood, leading to delayed cardiac evaluations.

    Purpose of the Study:

    • To establish recommendations for optimal cardiovascular evaluation in individuals with confirmed DMD or BMD.
    • To guide healthcare specialists in managing the cardiac aspects of these muscular dystrophies.

    Main Methods:

    • This is a policy statement, not a research study.
    • It synthesizes current knowledge and expert opinion.
    • Recommendations are based on established clinical practice and literature review.

    Main Results:

    • Cardiovascular complications are a major cause of morbidity and mortality in DMD and BMD.
    • Current practice often delays cardiac assessment until symptoms are apparent.
    • Proactive and regular cardiovascular evaluation is crucial.

    Conclusions:

    • Early and consistent cardiovascular monitoring is essential for patients with DMD and BMD.
    • Implementing these recommendations can improve patient outcomes.
    • This policy aims to standardize and optimize cardiac care for individuals with these conditions.

    Related Concept Videos

    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Cardiomyopathy VI: Nursing Management01:29

    Cardiomyopathy VI: Nursing Management

    Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
    Satellite Stem Cells and Muscular Dystrophy01:21

    Satellite Stem Cells and Muscular Dystrophy

    Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
    Assessment of the Cardiovascular System II: Inspection01:29

    Assessment of the Cardiovascular System II: Inspection

    Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
    Head and Neck